china glp-1 has approved Pfizer's treatment ​Xianweiying for long-term weight management in overweight or ‌obese adults, the U.S. drugmaker said, opens new tab on WeChat on Friday, boosting competition in a market First China Weight Loss Drug

Semaglutide GLP-1 is suitable for patients with a BMI of 30+ (obesity) or 27+ (overweight) with a weight-related comorbidity

Gharibzahedi, A

If domperidone is considered, it should only be used at the lowest effective dose for the shortest possible duration (usually no more than 7 days) due to cardiac safety concerns, and is contraindicated in people with certain heart conditions or those taking medications that affect heart rhythm

This phenomenon is reminiscent of autoprotection observed in experimental animals, where initial exposure to the sub-toxic doses of acetaminophen protects rodents from subsequent lethal doses of the drug [59,60]

In situ electrodeposition of bismuth oxide nanowires@ MWNT on the carbon fiber microelectrode for the sensitively electrochemical detection of folic acid